{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:12:58Z","timestamp":1778825578382,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031698","name":"Taiwan Blood Services Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jmii.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:25:32Z","timestamp":1777674332000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence of SARS-CoV-2 antibodies among blood donors in Taiwan during the initial COVID-19 surge, April\u2013July 2021"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2806-2398","authenticated-orcid":false,"given":"Cha-Shien","family":"Yen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7528-0199","authenticated-orcid":false,"given":"Chia-Ping","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Tsan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yueh","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-1699","authenticated-orcid":false,"given":"Chi-Tai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7114-3418","authenticated-orcid":false,"given":"Jen-Hsiang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2026.04.002_bib20","article-title":"Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing","author":"Hayden","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.jmii.2026.04.002_bib21","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.vaccine.2022.03.009","article-title":"Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: a complementary tool to detect breakthrough infections after COVID-19 vaccination?","volume":"40","author":"van den Hoogen","year":"2022","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jmii.2026.04.002_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.mayocp.2022.02.002","article-title":"Identification of natural SARS-CoV-2 infection in seroprevalence studies among vaccinated populations","volume":"97","author":"Demmer","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"158","key":"10.1016\/j.jmii.2026.04.002_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jmii.2026.04.002_bib2","article-title":"Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients","volume":"3","author":"Ho","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"10.1016\/j.jmii.2026.04.002_bib16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jmii.2021.03.018","article-title":"A seroprevalence study of COVID-19 at a campus in southern Taiwan","volume":"54","author":"Li","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.jmii.2026.04.002_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad614","article-title":"Seroprevalence of Anti-SARS-CoV-2 remained extremely low in Taiwan until the Vaccination Program was implemented","volume":"11","author":"Chen","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"10.1016\/j.jmii.2026.04.002_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.32923","article-title":"Seroprevalence of unidentified SARS-CoV-2 infection in Hong Kong during 3 pandemic waves","volume":"4","author":"Boon","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"14","key":"10.1016\/j.jmii.2026.04.002_bib8","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.2021.15161","article-title":"Estimated US Infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021","volume":"326","author":"Jones","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jmii.2026.04.002_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2022.9745","article-title":"Updated US Infection- and vaccine-induced SARS-CoV-2 seroprevalence estimates based on blood donations, July 2020-December 2021","volume":"328","author":"Jones","year":"2022","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jmii.2026.04.002_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.15585\/mmwr.mm7222a3","article-title":"Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status - united States, April 2021-September 2022","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.jmii.2026.04.002_bib13","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1186\/s12889-024-20364-5","article-title":"Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis","volume":"24","author":"Ukwishaka","year":"2024","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.jmii.2026.04.002_bib14","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1007\/s00277-023-05331-1","article-title":"Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region","volume":"102","author":"Sticchi","year":"2023","journal-title":"Ann Hematol"},{"issue":"39","key":"10.1016\/j.jmii.2026.04.002_bib15","first-page":"268","article-title":"SARS-CoV-2 seroepidemiological study and long-term trend analysis in Taiwan","author":"Lee","year":"2023","journal-title":"Taiwan Epidemiol Bull"},{"issue":"4","key":"10.1016\/j.jmii.2026.04.002_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3201\/eid2804.211961","article-title":"SARS-CoV-2 IgG seroprevalence among blood donors as a monitor of the COVID-19 epidemic, Brazil","volume":"28","author":"Chaves","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2026.04.002_bib7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41467-021-21503-x","article-title":"The prevalence of antibodies to SARS-CoV-2 among blood donors in China","volume":"12","author":"Chang","year":"2021","journal-title":"Nat Commun"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:46:15Z","timestamp":1778823975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118226000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":16,"alternative-id":["S1684118226000472"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2026.04.002","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of SARS-CoV-2 antibodies among blood donors in Taiwan during the initial COVID-19 surge, April\u2013July 2021","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}